期刊文献+

肿瘤分子标志联合检测对胸腔积液鉴别诊断价值分析 被引量:10

Combined measurement of tumor molecular marker in pleural effusionsin differential diagnosis of pleural effusions
原文传递
导出
摘要 目的:探讨癌胚抗原(CEA)、糖类抗原125(CA125)、细胞角蛋白片段19(CYFRA21-1)和神经元特异性烯醇化酶(NSE)联合检测在良恶性胸腔积液鉴别诊断中的价值。方法:电化学发光法检测56例恶性胸腔积液患者和78例良性胸腔积液患者的CEA、CA125、CYFRA21-1和NSE的浓度和阳性表达率,比较其差异。结果:恶性组与良性组CEA(t=5.102)、CA125(t=4.294)、CYFRA21-1(t=3.602)和NSE(t=2.142)浓度进行比较,差异均有统计学意义,P值均<0.05。恶性组与良性组CEA(χ2=69.07)、CA125(χ2=67.34)、CYFRA21-1(χ2=73.99)和NSE(χ2=78.59)阳性率进行比较,差异有统计学意义,P值均<0.01。单项检测各种肿瘤分子标志诊断良恶性胸腔积液的敏感度和特异性以CEA最高,分别为33.93%(19/56)和97.44%(76/78)。联合检测较单项检测敏感度明显增高。2项检测以CEA和CYFRA21-1敏感性和特异性最高,分别为44.64%(25/56)和96.15%(75/78)。3项检测以CEA、CYFRA21-1和NSE联合检测敏感性和特异性最高,分别为51.79%(29/56)和91.03%(71/78)。CEA+CA125+CYFRA21-1+NSE 4项联合检测效果最佳,其敏感性高达53.57%(30/56),特异度达85.90%(67/78)。结论:胸腔积液CEA、CA125、CYFRA21-1和NSE联合检测在良恶性胸腔积液鉴别诊断中有重要意义。 OBJECTIVE:To analysis the value of differential diagnosis of combined measurement of CEA,CA125, CYFRA21-1,NSE in pleural effusions. METHODS: CEA, CA125,CYFRA21-1 and NSE in pleural effusions were meas- ured by electrochemiluminescent immunoassay in one group of 56 patients with malignant pleural effusion and another group of 78 patients with benign lung diseases. The concentration and the positive rate between two groups of patients were compared. RESULTS:Between two groups the concentration of CEA(t= 5. 102), CA125 (t= 4. 294), CYFRA21-1 (t=3. 602) and NSE (t=2. 142) were significantly different (P〈O. 05). Between the two groups the difference of posi- tive rates of CEA (X2 =69.07),CA125(X2 =67.34),CYFRA21-1(X2 =73.99) and NSE (X2 =78.59) were statistically significant (P〈0.01). CEA had the highest sensitivity and specificity when a single tumor marker was used in differential diagnosis from pleural effusions 1-33.93% (19/56) and 97.44% (76/78)] ,and the combined measurement of several tumor molecular markers had higher sensitivity than that of the single marker. When 2 markers was used, the combination of CEA and CYFRA21-1 had the highest sensitivity and specificity [44. 64% (25/56) and 96.15% (75/78)]. And when 3 markers was used, the combination of CEA, CYFRA21-1, NSE had the highest sensitivity and specificity [51. 79% (29/56) and 91.03%(71/78)]. The combination of CEA+CA125-4-CYFRA21-1+NSE had the most significant effect, its sensitivity was as high as 53.57% (30/56) ,and its specificity was 85.90% (67/78). CONCLUSlON:CEA,CA125 ,CY- FRA21-1 ,NSE detections from benign and malignant pleural effusion have important meanings in differential diagnosis.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第10期772-774,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 胸腔积液 联合检测 鉴别诊断 肿瘤分子标志物 CEA CA125 CYFRA21-1 NSE pleural effusions combined measurement differential diagnosis tumor molecular marker CEA CA125 CYFRE21-1 NSE
  • 相关文献

参考文献14

二级参考文献101

共引文献95

同被引文献150

  • 1王新荣.胸水ADA、CEA、CA125、CA153水平在结核性与恶性胸水中的表达与意义[J].中国老年学杂志,2014,34(12):3290-3292. 被引量:8
  • 2罗杰,冷卫东,曾宪涛,等.系统评价Meta分析理论与实践[M].北京:军事医学科学出版社,2013:508-12.
  • 3李哓松.医学统计学[M].2版.北京:高等教育出版社,2008:236-237.
  • 4Spira A, Ettinger DS. Multidisciplinary management of lung cancer[J]. New England Journal of Medicine, 2004,350(4): 379- 392.
  • 5Kasprzak A, Zabel M, Biczysko W. Selected markers (ehromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5 )in diagnosis and prognosis of neuroendocrine pulmonary tumours[J]. Pol J Pathol, 2007,58 (1): 23 -33.
  • 6陈锋,曾雪峰,包勇,等.联合检测血清肿瘤标志物对早期肺癌的临床诊断价值[J].全科医疗,20lO,24(11):90-91.
  • 7Sun J,Shannon M, Ando Y, et al. Serum metabolomic profiles from patients with acute kidney injury: A pilot study[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2012,893-894 : 107-113.
  • 8Hasokawa M, Shinohara M, Tsugawa H, et al. Identification of biomarkers of stent restenosis with serum metabolomic profiling using gas chromatography/mass spectrometry[J]. Circ J, 2012, 76(8) : 1864-1873.
  • 9Jemal A,Siegel R,Xu J,et.al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5):277-300.
  • 10Molina J R,Yang P,Cassivi S D,et al.Non-small cell lung cancer:epidemiology,risk factors,treatment,and survivorship[J].Mayo Clin Proc,2008,83(5):584-594.

引证文献10

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部